1. Academic Validation
  2. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

  • Science. 2009 May 15;324(5929):930-5. doi: 10.1126/science.1170116.
Mamta Tahiliani 1 Kian Peng Koh Yinghua Shen William A Pastor Hozefa Bandukwala Yevgeny Brudno Suneet Agarwal Lakshminarayan M Iyer David R Liu L Aravind Anjana Rao
Affiliations

Affiliation

  • 1 Department of Pathology, Harvard Medical School and Immune Disease Institute, 200 Longwood Avenue, Boston, MA 02115, USA.
Abstract

DNA cytosine methylation is crucial for retrotransposon silencing and mammalian development. In a computational search for Enzymes that could modify 5-methylcytosine (5mC), we identified TET proteins as mammalian homologs of the trypanosome proteins JBP1 and JBP2, which have been proposed to oxidize the 5-methyl group of thymine. We show here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent Enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro. hmC is present in the genome of mouse embryonic stem cells, and hmC levels decrease upon RNA interference-mediated depletion of TET1. Thus, TET proteins have potential roles in epigenetic regulation through modification of 5mC to hmC.

Figures